Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NORDTHY FYSIOTERAPI, AUTORISEREDE FYSIOTERAPEUTER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.9% 3.7% 3.9% 2.4% 1.5% 1.8% 7.9% 7.6%   Credit score (0-100)   41 52 49 64 74 72 31 32   Credit rating   BBB BBB BBB BBB A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.1 19.0 4.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,598 5,138 6,684 7,279 8,953 8,522 0.0 0.0   EBITDA   1,684 1,148 1,091 972 1,675 849 0.0 0.0   EBIT   1,505 989 932 664 1,290 513 0.0 0.0   Pre-tax profit (PTP)   1,508.8 979.9 928.3 630.6 1,201.7 442.3 0.0 0.0   Net earnings   1,174.8 762.1 726.8 490.1 933.9 345.2 0.0 0.0   Pre-tax profit without non-rec. items   1,509 980 928 631 1,202 442 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   472 363 1,579 2,494 1,161 1,005 0.0 0.0   Shareholders equity total   1,998 2,160 2,286 2,777 3,710 4,056 3,931 3,931   Interest-bearing liabilities   0.0 0.0 0.0 1,925 1,775 1,865 0.0 0.0   Balance sheet total (assets)   2,437 3,078 3,160 5,349 6,405 6,620 3,931 3,931   Net Debt   -1,195 -1,869 -274 1,748 422 1,700 -2,596 -2,596     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,598 5,138 6,684 7,279 8,953 8,522 0.0 0.0   Gross profit growth   2.9% -22.1% 30.1% 8.9% 23.0% -4.8% -100.0% 0.0%   Employees   11 11 12 14 15 16 0 0   Employee growth %   0.0% 0.0% 9.1% 16.7% 7.1% 6.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,437 3,078 3,160 5,349 6,405 6,620 3,931 3,931   Balance sheet change%   6.3% 26.3% 2.6% 69.3% 19.8% 3.4% -40.6% 0.0%   Added value   1,684.2 1,148.3 1,091.5 971.9 1,597.2 849.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -317 -269 1,057 2,302 -1,898 -672 -1,005 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   22.8% 19.2% 13.9% 9.1% 14.4% 6.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   63.9% 36.1% 30.1% 15.8% 22.5% 8.6% 0.0% 0.0%   ROI %   81.3% 46.7% 41.2% 19.0% 25.5% 9.7% 0.0% 0.0%   ROE %   63.2% 36.7% 32.7% 19.4% 28.8% 8.9% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   82.4% 70.3% 72.4% 51.9% 58.0% 61.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -71.0% -162.8% -25.1% 179.8% 25.2% 200.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 69.3% 47.8% 46.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 4.3% 6.5% 6.5% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   4.2 3.2 1.6 1.4 3.6 4.3 0.0 0.0   Current Ratio   4.1 3.1 1.6 1.4 3.6 4.1 0.0 0.0   Cash and cash equivalent   1,195.0 1,869.1 274.2 177.2 1,353.1 164.4 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,364.1 1,738.5 545.8 283.7 2,577.2 3,248.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   153 104 91 69 106 53 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   153 104 91 69 112 53 0 0   EBIT / employee   137 90 78 47 86 32 0 0   Net earnings / employee   107 69 61 35 62 22 0 0